Additionally, we did not analyze the association of TLR4 polymorphisms with other outcomes of HCV infection such as fibrosis, drug treatment and HCC due to lack of sufficient data for eligible analysis. The gene discussed is TLR4; the disease is hepatocellular carcinoma.